TY - JOUR PY - 2012 DA - 2012// TI - EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2011.12.001 DO - 10.1016/j.jhep.2011.12.001 ID - ref1 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. PY - 2011 DA - 2011// TI - Management of hepatocellular carcinoma: an update JO - Hepatology VL - 53 UR - https://doi.org/10.1002/hep.24199 DO - 10.1002/hep.24199 ID - Bruix2011 ER - TY - JOUR AU - Cheng, A. L. AU - Kang, Y. K. AU - Chen, Z. AU - Tsao, C. J. AU - Qin, S. AU - Kim, J. S. PY - 2009 DA - 2009// TI - Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(08)70285-7 DO - 10.1016/S1470-2045(08)70285-7 ID - Cheng2009 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Liu, P. H. AU - Hsia, C. Y. AU - Lee, Y. H. AU - Hsu, C. Y. AU - Huang, Y. H. AU - Su, C. W. PY - 2015 DA - 2015// TI - Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma JO - J Surg Oncol VL - 111 UR - https://doi.org/10.1002/jso.23854 DO - 10.1002/jso.23854 ID - Liu2015 ER - TY - JOUR AU - Hsu, C. Y. AU - Liu, P. H. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Huang, Y. H. AU - Chiou, Y. Y. PY - 2015 DA - 2015// TI - Hepatocellular carcinoma patients with performance status 1 deserve new classification and treatment algorithm in the BCLC system JO - Medicine (Baltimore) VL - 94 UR - https://doi.org/10.1097/MD.0000000000001223 DO - 10.1097/MD.0000000000001223 ID - Hsu2015 ER - TY - JOUR AU - Tsai, Y. J. AU - Hsu, C. Y. AU - Huang, Y. H. AU - Su, C. W. AU - Lin, H. C. AU - Lee, R. C. PY - 2011 DA - 2011// TI - Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma JO - Hepatol Int VL - 5 UR - https://doi.org/10.1007/s12072-011-9276-9 DO - 10.1007/s12072-011-9276-9 ID - Tsai2011 ER - TY - JOUR AU - Adhoute, X. AU - Penaranda, G. AU - Raoul, J. L. AU - Edeline, J. AU - Blanc, J. F. AU - Pol, B. PY - 2017 DA - 2017// TI - Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort JO - World J Gastroenterol VL - 23 UR - https://doi.org/10.3748/wjg.v23.i14.2545 DO - 10.3748/wjg.v23.i14.2545 ID - Adhoute2017 ER - TY - JOUR AU - Adhoute, X. AU - Penaranda, G. AU - Raoul, J. L. AU - Bourlière, M. PY - 2016 DA - 2016// TI - Nomogram of the Barcelona clinic liver Cancer system: external validation in European patients JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13171 DO - 10.1111/liv.13171 ID - Adhoute2016 ER - TY - JOUR AU - Hsu, C. Y. AU - Liu, P. H. AU - Hsia, C. Y. AU - Lee, Y. H. AU - Al Juboori, A. AU - Lee, R. C. PY - 2016 DA - 2016// TI - Nomogram of the Barcelona clinic liver Cancer system for individual prognostic prediction in hepatocellular carcinoma JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13114 DO - 10.1111/liv.13114 ID - Hsu2016 ER - TY - JOUR AU - Bruix, J. AU - Sherman, M. AU - Llovet, J. M. AU - Beaugrand, M. AU - Lencioni, R. AU - Burroughs, A. K. PY - 2001 DA - 2001// TI - Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the liver JO - J Hepatol VL - 35 UR - https://doi.org/10.1016/S0168-8278(01)00130-1 DO - 10.1016/S0168-8278(01)00130-1 ID - Bruix2001 ER - TY - JOUR AU - Lee, Y. H. AU - Hsu, C. Y. AU - Hsia, C. Y. AU - Huang, Y. H. AU - Su, C. W. AU - Chiou, Y. Y. PY - 2013 DA - 2013// TI - Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma JO - Hepatol Int VL - 7 UR - https://doi.org/10.1007/s12072-012-9375-2 DO - 10.1007/s12072-012-9375-2 ID - Lee2013 ER - TY - JOUR AU - Lee, Y. H. AU - Hsu, C. Y. AU - Huang, Y. H. AU - Su, C. W. AU - Lin, H. C. AU - Hsia, C. Y. AU - Huo, T. I. PY - 2013 DA - 2013// TI - α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma JO - J Gastrointest Surg VL - 17 UR - https://doi.org/10.1007/s11605-012-2081-5 DO - 10.1007/s11605-012-2081-5 ID - Lee2013 ER - TY - JOUR AU - Hsu, C. Y. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Huang, Y. H. AU - Su, C. W. AU - Lin, H. C. PY - 2013 DA - 2013// TI - Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona clinic liver Cancer system JO - Hepatology VL - 57 UR - https://doi.org/10.1002/hep.25950 DO - 10.1002/hep.25950 ID - Hsu2013 ER - TY - JOUR AU - Mazzaferro, V. AU - Regalia, E. AU - Doci, R. AU - Andreola, S. AU - Pulvirenti, A. AU - Bozzetti, F. PY - 1996 DA - 1996// TI - Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis JO - N Engl J Med VL - 334 UR - https://doi.org/10.1056/NEJM199603143341104 DO - 10.1056/NEJM199603143341104 ID - Mazzaferro1996 ER - TY - JOUR AU - Austin, P. C. PY - 2014 DA - 2014// TI - A comparison of 12 algorithms for matching on the propensity score JO - Stat Med VL - 33 UR - https://doi.org/10.1002/sim.6004 DO - 10.1002/sim.6004 ID - Austin2014 ER - TY - JOUR AU - Austin, P. C. AU - Schuster, T. PY - 2016 DA - 2016// TI - The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: a simulation study JO - Stat Methods Med Res VL - 25 UR - https://doi.org/10.1177/0962280213519716 DO - 10.1177/0962280213519716 ID - Austin2016 ER - TY - JOUR AU - Pinter, M. AU - Hucke, F. AU - Graziadei, I. AU - Vogel, W. AU - Maieron, A. AU - Königsberg, R. PY - 2012 DA - 2012// TI - Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib JO - Radiology VL - 263 UR - https://doi.org/10.1148/radiol.12111550 DO - 10.1148/radiol.12111550 ID - Pinter2012 ER - TY - JOUR AU - Liu, P. H. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Hsu, C. Y. AU - Huang, Y. H. AU - Chiou, Y. Y. PY - 2014 DA - 2014// TI - Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis JO - Ann Surg Oncol VL - 21 UR - https://doi.org/10.1245/s10434-014-3510-3 DO - 10.1245/s10434-014-3510-3 ID - Liu2014 ER - TY - JOUR AU - Yang, T. AU - Lin, C. AU - Zhai, J. AU - Shi, S. AU - Zhu, M. AU - Zhu, N. PY - 2012 DA - 2012// TI - Surgical resection for advanced hepatocellular carcinoma according to Barcelona clinic liver Cancer (BCLC) staging JO - J Cancer Res Clin Oncol VL - 138 UR - https://doi.org/10.1007/s00432-012-1188-0 DO - 10.1007/s00432-012-1188-0 ID - Yang2012 ER - TY - JOUR AU - Shiina, S. AU - Tateishi, R. AU - Arano, T. AU - Uchino, K. AU - Enooku, K. AU - Nakagawa, H. PY - 2012 DA - 2012// TI - Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors JO - Am J Gastroenterol VL - 107 UR - https://doi.org/10.1038/ajg.2011.425 DO - 10.1038/ajg.2011.425 ID - Shiina2012 ER - TY - JOUR AU - Han, K. H. AU - Kudo, M. AU - Ye, S. L. AU - Choi, J. Y. AU - Poon, R. T. AU - Seong, J. PY - 2011 DA - 2011// TI - Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia JO - Oncology VL - 81 UR - https://doi.org/10.1159/000333280 DO - 10.1159/000333280 ID - Han2011 ER - TY - JOUR AU - Poon, D. AU - Anderson, B. O. AU - Chen, L. T. AU - Tanaka, K. AU - Lau, W. Y. AU - Van Cutsem, E. PY - 2009 DA - 2009// TI - Management of hepatocellular carcinoma in Asia: consensus statement from the Asian oncology summit 2009 JO - Lancet Oncol. VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70241-4 DO - 10.1016/S1470-2045(09)70241-4 ID - Poon2009 ER - TY - JOUR AU - Hsu, C. Y. AU - Liu, P. H. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Huang, Y. H. AU - Chiou, Y. Y. PY - 2015 DA - 2015// TI - Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis JO - Ann Surg Oncol VL - 22 UR - https://doi.org/10.1245/s10434-014-4151-2 DO - 10.1245/s10434-014-4151-2 ID - Hsu2015 ER - TY - JOUR AU - Liu, P. H. AU - Hsu, C. Y. AU - Hsia, C. Y. AU - Lee, Y. H. AU - Huang, Y. H. AU - Chiou, Y. Y. PY - 2016 DA - 2016// TI - Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma ≤ 2  cm in a propensity score model JO - Ann Surg VL - 263 UR - https://doi.org/10.1097/SLA.0000000000001178 DO - 10.1097/SLA.0000000000001178 ID - Liu2016 ER - TY - JOUR AU - Liu, P. H. AU - Hsu, C. Y. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Huang, Y. H. AU - Su, C. W. PY - 2015 DA - 2015// TI - When to perform surgical resection or radiofrequency ablation for early hepatocellular carcinoma?: a nomogram-guided treatment strategy JO - Medicine (Baltimore) VL - 94 UR - https://doi.org/10.1097/MD.0000000000001808 DO - 10.1097/MD.0000000000001808 ID - Liu2015 ER - TY - JOUR AU - Menon, K. V. AU - Hakeem, A. R. AU - Heaton, N. D. PY - 2014 DA - 2014// TI - Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria JO - Aliment Pharmacol Ther VL - 40 UR - https://doi.org/10.1111/apt.12922 DO - 10.1111/apt.12922 ID - Menon2014 ER - TY - JOUR AU - Maggs, J. R. AU - Suddle, A. R. AU - Aluvihare, V. AU - Heneghan, M. A. PY - 2012 DA - 2012// TI - Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma JO - Aliment Pharmacol Ther VL - 35 UR - https://doi.org/10.1111/j.1365-2036.2012.05072.x DO - 10.1111/j.1365-2036.2012.05072.x ID - Maggs2012 ER - TY - JOUR AU - Bruix, J. AU - Tak, W. Y. AU - Gasbarrini, A. AU - Santoro, A. AU - Colombo, M. AU - Lim, H. Y. PY - 2013 DA - 2013// TI - Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2013.05.028 DO - 10.1016/j.ejca.2013.05.028 ID - Bruix2013 ER - TY - JOUR AU - Luo, C. P. AU - Mo, H. Y. AU - Wu, L. L. AU - Ma, Y. AU - Peng, N. F. PY - 2017 DA - 2017// TI - Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma JO - Eur J Cancer VL - 71 UR - https://doi.org/10.1016/j.ejca.2016.09.040 DO - 10.1016/j.ejca.2016.09.040 ID - Luo2017 ER -